ProfessionalHybridActive

EMBARK OPEN Access

EMBARK Open Access is a comprehensive course designed to equip care providers with the skills and knowledge to provide ethical, culturally competent, and trauma-informed psychedelic facilitation.

Provider

Helus Pharma

English

Schedule

Dates not announced

25 years

Enrollment

Free

Decision Summary

Best fit
Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.
Format
Hybrid
Time commitment
25 years
Credential signal
Published in Frontiers in Psychology
Delivery
Online

Course Overview

EMBARK Open Access (OA) is a comprehensive course designed to equip care providers with the skills and knowledge to provide ethical, culturally competent, and trauma-informed psychedelic facilitation. Based on the innovative EMBARK model, which combines elements from over a dozen previous approaches, this course focuses on six clinical domains and four care cornerstones that ensure effective therapeutic support within a broader framework of collective caregiving.

The EMBARK Training Program offers a blended model of live and self-guided activities, preparing participants to become Certified EMBARK Facilitators. The curriculum includes didactics, experiential activities, group discussions, independent study, and clinical supervision, led by a team of 28 faculty members, supervisors, and advisors. EMBARK's creators, Bill Brennan, PhD, and Alex Belser, PhD, have developed the program based on process evidence in psychedelic clinical practice and the experiences of senior teachers and supervisors.

The EMBARK model has been published in the peer-reviewed journal Frontiers in Psychology and can be adapted to different clinical indications and problems, such as depression, alcohol use disorder, and anxiety. With its transdiagnostic treatment model and commitment to accessibility, EMBARK Open Access aims to revolutionize mental healthcare by providing innovative psychedelic-based treatment options.

Who is this for?

Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.

About the Provider

Helus Pharma is the commercial operating name of Cybin Inc., a clinical-stage biopharmaceutical company developing proprietary Novel Serotonergic Agonists (NSAs) — synthetic deuterated molecules designed to activate serotonin pathways and promote neuroplasticity. Operating across Canada, the US, UK, and Ireland, Helus holds over 100 granted patents and 250+ pending applications across its NSA portfolio. Its lead asset, HLP003 (formerly CYB003, a deuterated psilocin analogue), has received FDA Breakthrough Therapy Designation for the adjunctive treatment of major depressive disorder and is in two concurrent Phase 3 trials: APPROACH™ (topline data Q4 2026) and EMBRACE™. A key differentiator is its adjunctive design — allowing patients to continue background antidepressant medications without washout. HLP004 (a deuterated DMT analogue for intramuscular use) posted encouraging Phase 2 topline results in GAD in March 2026: 10.4-point HAM-A reduction at 6 weeks, 67% responders at 6 months, and an ~90-minute in-clinic session window. US composition-of-matter patent coverage through at least 2041.

View all Helus Pharma courses

Course FAQ

Who is this course for?

Care providers and facilitator trainees seeking training in psychedelic facilitation and psychedelic-assisted therapy support.

What is the format and time commitment?

Format: Hybrid. Time commitment: 25 years.

How much does it cost?

The listed price is $0. Confirm the latest tuition, fees, and payment options on the provider website.

Does it offer a certificate or CE/CME credit?

Accreditation note: Published in Frontiers in Psychology. Confirm credential eligibility directly with the provider before enrolling.

Are dates currently announced?

This active course does not have a listed upcoming cohort date yet. Check the provider website for current schedule details.

Is this course currently available?

The current listing status is Active. Use the provider website for the latest enrollment status.

Related Courses

View all courses
ActiveCertificate option

Navigating Psychedelics for Clinicians and Wellness Practitioners

By Psychedelics Today

Shares course skills and categories

Navigating Psychedelics for Clinicians and Therapists is a comprehensive course designed specifically for mental health professionals to educate them on psychedelics and psychedelic integration.

Dates not announced

Source lists: Estimated 13.5 hours

Delivery: Online + Self-paced

No medicine self-experience listed

4 years
Professional
$907
ActiveCertificate option

Psilocybin Facilitator Training

By Clinical Cognitive Facilitator Training

Shares course skills and categories

The Psilocybin Facilitator Training from the ‘Clinical Cognitive Facilitator Training’ is one of the accepted programs for the Oregon Facilitation Program, but currently their site doesn’t connect nor any other information about their course can be found.

Dates not announced

Delivery: Online + Beaverton, United States

Includes medicine self-experience

4 months
Professional
$8,558